Bruker Corp (BRKR) SEC Filing 10-Q Quarterly report for the period ending Sunday, September 30, 2018

Exhibit 99.1

Bruker Reports Third Quarter 2018 Financial Results

BILLERICA, Mass. — November 1, 2018 — Bruker Corporation (NASDAQ: BRKR) today announced financial results for its third quarter and nine months ended September 30, 2018.

Bruker’s revenues for the third quarter of 2018 were $466.6 million, an increase of 7.1% compared to the third quarter of 2017. In the third quarter of 2018, Bruker’s year-over-year organic revenue growth was 7.0%. Growth from acquisitions was 1.5%, while foreign currency translation had a negative effect of 1.4%.

Third quarter 2018 Bruker Scientific Instruments (BSI) segment revenues of $417.1 million increased 6.8%, compared to the third quarter of 2017, including organic growth of 6.5%. Third quarter 2018 BEST segment revenues of $50.9 million increased 10.4%, compared to the third quarter of 2017, including organic growth, net of intercompany eliminations, of 11.1%.

Third quarter 2018 GAAP operating income was $69.1 million, compared to $51.3 million in the third quarter of 2017. Non-GAAP operating income was $83.3 million, compared to $65.8 million in the third quarter of 2017. On a non-GAAP basis, Bruker’s third quarter 2018 operating margin of 17.9% increased 280 basis points compared to 15.1% in the third quarter of 2017. Strong operating leverage, favorable product mix and operational improvements contributed to the year-over-year margin increase.

Third quarter 2018 GAAP diluted earnings per share (EPS) were $0.28, an increase of 21.7% compared to $0.23 in the third quarter of 2017. Third quarter 2018 non-GAAP diluted EPS were $0.37, an increase of 27.6% compared to $0.29 in the third quarter of 2017.

For the first nine months of 2018, Bruker’s revenues increased 8.6% to $1,342.0 million, from $1,235.4 million in the first nine months of 2017. In the first nine months of 2018, Bruker’s year-over-year organic revenue growth was 4.7%. Favorable foreign currency translation contributed 3.0% to revenue growth, while growth from acquisitions was 0.9%.

In the first nine months of 2018, BSI segment revenues of $1,206.5 million increased 9.7%, compared to the first nine months of 2017, including organic growth of 5.8%. BEST segment revenues in the first nine months of 2018 of $139.2 million declined 0.7%, compared to the first nine months of 2017, including an organic decline, net of intercompany eliminations, of 4.8%.

In the first nine months of 2018, GAAP operating income was $156.0 million, compared to $124.2 million in the first nine months of 2017. Non-GAAP operating income was $195.1 million, compared to $168.5 million in the first nine months of 2017. On a non-GAAP basis, Bruker’s operating margin in the first nine months of 2018 of 14.5% increased 90 basis points, compared to 13.6% in the first nine months of 2017. During the first nine months of 2018, volume leverage and operational improvements more than offset a strong unfavorable impact from changes in foreign currency rates on operating margins, which occurred primarily in the first half of the year.

In the first nine months of 2018, GAAP EPS were $0.65, an increase of 27.5% compared to $0.51 in the first nine months of 2017. Non-GAAP EPS for the first nine months of 2018 were $0.86, an increase of 22.9% over $0.70 in the first nine months of 2017.

A reconciliation of non-GAAP to GAAP financial measures is provided in the tables accompanying this press release.